{"": [112, 1851, 0], "Introduction": [1852, 5178, 0], "Generation of recombinant v-NY-S and MVA-S viruses expressing full-length SARS-CoV-2 S protein": [5188, 5900, 0], "v-NY-S and MVA-S prime-boost vaccination regimens generate neutralizing antibodies in immunized C57BL/6 mice": [5901, 8784, 0], "v-NY-S and MVA-S immunization generates a TH1-biased immune response in mice": [8785, 10485, 0], "v-NY-S and MVA-S immunization generated neutralizing antibodies in immunized Syrian hamsters": [10486, 11868, 0], "v-NY-S and MVA-S immunization reduce lung pathology in SARS-CoV-2-infected Syrian hamsters": [11869, 15928, 0], "Single immunization with v-NY-S partially protects Syrian hamsters from SARS-CoV-2 infection": [15929, 17822, 0], "Sera from vaccinated mice partially cross-neutralize SARS-CoV-2 variants of concern": [17823, 19264, 0], "A heterologous prime-boost immunization regimen with v-NY-S generates higher titers of neutralizing antibodies than a homologous prime-boost regimen": [19265, 20951, 0], "Results": [5179, 20951, 1], "Discussion": [20952, 32136, 0], "Animals and ethics statement": [32160, 32939, 0], "Cells, viruses, and reagents": [32940, 33609, 0], "Construction of recombinant vaccinia viruses": [33610, 34718, 0], "Immunofluorescence staining of cell surface S protein": [34719, 35616, 0], "Prime-boost immunization regimens in mice": [35617, 37447, 0], "Prime-boost immunization regimens in Syrian hamsters": [37448, 38566, 0], "Immunoblotting": [38567, 40732, 0], "Flow cytometry analysis of cell-surface SARS-CoV-2 S protein expression": [40733, 42320, 0], "SARS-CoV-2 pseudotyped virus neutralization assay": [42321, 43376, 0], "SARS-CoV-2 neutralization assay": [43377, 43877, 0], "Immunoglobulin ELISA for SARS-CoV-2 S-specific antibodies": [43878, 45000, 0], "ELISpot assay of mouse splenocytes": [45001, 45813, 0], "Analyses of T effector memory (Tem) cells": [45814, 46931, 0], "Syrian hamster challenge experiments": [46932, 47677, 0], "Quantification of viral titers in lung tissues by cell culture infection assay": [47678, 48463, 0], "Real-time RT-PCR for SARS-CoV-2 RNA quantification": [48464, 49858, 0], "Histopathology": [49859, 50579, 0], "Statistical analyses": [50580, 50931, 0], "Materials and methods": [32137, 50931, 1], "Supporting information": [50932, 51323, 0]}